NodeGuardian

Krishna Srinivasan, a director at CS Disco, Inc., boosted his direct ownership by buying 45,000 shares in February 2026, consisting of 40,000 shares at $3.25 and 5,000 shares at $2.77, alongside substantial indirect holdings.

LPL Financial, Raymond James, and Wells Fargo Advisors have intensified recruitment, adding over $1 billion in client assets. Key hires include Consilium Wealth, Jerry Knight, and three practices from Wells Fargo, reflecting a competitive wealth management landscape.

CVS Caremark is being sued by a roofers' union for allegedly inflating prescription drug costs through a "Formulary Manipulation Scheme," favoring costly medications and channeling payments improperly, leading to increased expenses for clients.

Biomerica (BMRA) has received its first commercial order for the Hp Detect test in the UK, targeting Helicobacter pylori. This order marks a significant European market entry despite the company facing financial challenges.

Grupo Imobiliario GFA and Hilton are set to launch the Waldorf Astoria Residences Guadalajara, the first standalone Waldorf Astoria in Latin America, with 114 residences and luxury amenities, expected to open in Winter 2029.

Brookfield Corporation's 2025 Annual Report showcases record fundraising and acquisitions, achieving a 21% return on shares. The company emphasizes a long-term strategy targeting sustainable businesses, AI infrastructure, real estate, and strategic partnerships.

Pizza Hut celebrates March Madness with limited-edition menu items and a partnership with Warner Bros. to honor "Space Jam's" 30th anniversary, featuring a 'Triple Treat Box' and exclusive merchandise for Hut Rewards members.

Wells Fargo raised Waste Management's price target to $273 from $250, keeping an "overweight" rating, indicating a 15.7% potential upside. Despite a 7.1% revenue increase year-over-year, EPS and revenue slightly fell short of estimates.

Williams-Sonoma announced a 15% increase in its quarterly cash dividend to $0.76 per share, marking 20 years of consecutive increases. With a market cap of $21.8 billion, the company has returned $5 billion to shareholders in the last five years, despite being assessed as overvalued.

Keysight Technologies has expanded its 1.6T Ethernet interconnect validation portfolio, enhancing test systems to include advanced copper and optics technologies, essential for AI and high-performance computing networks amid rising data center power demands.

Barclays raised Equinix's price target to $1,020, maintaining an "equal weight" rating and indicating a 4.41% upside, despite the company's recent earnings miss and insider stock sales. Analysts generally rate it a "Moderate Buy" with an average target of $1,013.43.

This article provides a Net Asset Value (NAV) table for the Capital Group International Bond ETF (USD-hedged) (NYSE: CGIB), listing the market price and net asset value for the most recent dates, along with annual high and low prices. The table details the daily net asset value and market price for CGIB over the past 30 days.

J.B. Hunt Transport Services highlights that shippers are not shifting from truckload to intermodal despite a 30% rise in fuel prices. Intermodal offers cost savings and margin improvement, with the company focusing on network balance and revenue quality ahead of upcoming results.

Kimball Electronics' 2025 Guiding Principles Report highlights advancements in ESG initiatives, including a 9.3% reduction in greenhouse gas emissions, a 37% increase in renewable energy use, and improved CDP scores, positioning the company favorably for ESG investors.

Paychex Inc. reported disappointing fiscal Q3 results, with 2% revenue growth and a 3% decline in net income, leading to a 4.2% stock price drop. Challenges include cautious small business behavior, payroll growth slowing, and increased HR tech competition.

Pfizer's drug atirmociclib, a potential successor to Ibrance, demonstrated a 40% reduction in disease progression risk for metastatic breast cancer patients in Phase 2 trials. Analysts estimate peak sales of $2.6 billion, marking it as essential for Pfizer's oncology strategy.

The Form 10-K for Houlihan Lokey, Inc. details its fiscal year ending March 31, 2024, covering business operations, financial conditions, risk factors, and its dual-class stock structure as a controlled company.

Lam Research stock has increased 79.9% in six months, reaching $227.21, driven by strong quarterly results and a 11.5% sales growth rate over five years, with an operating margin of 31.9% and a forward P/E of 35.8.